BioSpace News Archive

FemPulse Corporation (FemPulse), a private, clinical-stage bioelectronic medicine company developing a novel therapy for the personalized treatment of overactive bladder (OAB) in women, announced today that the first participant has been enrolled in the Company’s clinical trial evaluating physiological responses to therapy delivered with the FemPulse System.

Production of new anti-cancer drugs at ADC Bio’s North Wales manufacturing plant has been boosted following completion of a new cleanroom facility, designed and built by WHP.

Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the July 11th life sciences conference are now available for on-demand viewing at VirtualInvestorConferences.com.

He will be responsible for new client acquisition and new plan development.

“Allergic Action” Campaign Creates Awareness of Allergic March & How to Reduce the Impact of Future Allergies

In June, the U.S. Senate took swift action and passed Senate Resolution 245 by unanimous consent. July 17, 2019 is officially “Glioblastoma Awareness Day” nationally (#GBMDay)! Glioblastoma (GBM) is the most common and deadly form of brain cancer.

Medline to expand CipherOutreach’s reach in market to help more patients benefit automated patient communication

Receiving the Sanitary License represents a key objective in the process of earning the GMP certification, required to sell pharma-grade products to the market.

Americord was one of the first family cord blood banks to store placental tissue and now offers this exciting product, which stores live amniotic membrane (AM), a first for the industry.

Novacap sees tremendous growth potential in Spectrum and will work with management to strengthen Spectrum’s position as a market leader in Home Care in Ontario.